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AIM OF THE STUDY:    
                           To detect the presence of microalbuminuria and red cell 
distribution   width in patients with  hypertension and to study, of hypertension 
the correlation of microalbuminuria and red cell distribution width in  patients on 
different stages 
Methods and Materials:  
                       Patients with hypertension of varying durations coming t o  
Royapettah Government Hospital were chosen as subjects For this study, during 
the period of April 2014 to September 2014. 
Inclusion criteria: 
Patients with essential hypertension coming to Government Royapettah 
Hospital 
 
 
 
 
 
Exclusion criteria: 
 Patients with severe anemia 
 Patient with acute blood loss 
 A total of 50 patients were studied. All subjects were investigated in 
detailincluding history of symptoms and signs suggestive of target organ damage, 
duration of  hypertension, drug history, previous blood pressure recordings, 
complete urine analysis, complete blood count with Red Cell Distribution width, 
biochemistry (urea, creatinine, FBS), ECG, 24 hours urine for 
microalbuminuria estimation was done by Immune Turbidmetric assay. Red 
cell distribution width was measured using Auto Hematology Analyser 
Study design:   cross sectional study design 
Place of study:   Government Royapettah Hospital, 
                           Department of Medicine. 
Collabrating Department: Department of hypertension, Government Royapettah 
Hospital,Chennai-14 
Period of study:  april 2014 to Sep 2014 
Sample size: 50 
Study population (subjects): hypertensive patients coming to Royapettah 
Government Hospital, Department of Intionernal Medicine and Department of 
Hypertens 
Inclusion criteria; 
Patients with essential hypertension coming to Government Royapettah 
Hospital 
 
 Exclusion criteria; Exclusion criteria: 
 Patients with severe anemia 
 Patient with acute blood loss 
 OUTCOMES:  To study the correlation brtween microalbuminuria and red 
cell distribution width in  patients on different stages of hypertension 
Sponsorship :   Nil 
Conflict of interest :   Nil 
Financial data    :  Nil 
Consent: Informed consent from all patients 
Ethical clearance :  APPROVED 
Principle Investigator: Dr.H.VASANTHAKUMAR, 
                                     Post Graduate, M.D.General Medicine, 
                                     Government Kilpauk Medical College and Hospital, 
                                     Chennai-10. 
 Supervisor &Guide :  PROF.Dr.R.SABARATNAVEL.M.D, 
                                        Professor of Internal Medicine, 
                                        Government Royapettah Hospital, 
                                        Chennai-14. 
KEY WORDS;  Hypertesnsion stages- Red cell distribution width – correlation with 
-Microalbuminuria  
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INTRODUCTION 
Even as our understanding of the underling pathophysiology of 
elevated arterial pressure has   advanced, in 90-95% of cases the 
etiology (and thus potentially the preventive cure) is still largely 
unknown. As a consequence, in most cases hypertension has to be 
treated non-specifically leading to a large number of minor side effects 
and high non-compliance rate.
1 
If  not  properly treated hypertension increases the incidence of 
early demise ,stroke, heart failure, renal injury . 
Hypertension has been ranked among the largest mortality risk 
factor in the world accounting for 5% of all deaths. Mild  elevation 
in  hypertension accounts for larger  proportion of cardiovascular deaths 
due to its high prevalence. 
The prevalence of hypertension in India is 59.9 69.9 per 1000 
in males and females respectively in urban population and 35.5 35.9 
per 1000 in males and females respectively in the rural population.
2  
Microalbuminuria has recently emerged as a marker of wide 
spread vascular damage in hypertension.
3 Hypertensives with 
microalbuminuria were found to have significantly higher prevalence of 
coronary artery disease, hypertensive retinopathy and cerebrovascular 
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disease when compared to patients without it. 
Microalbuminuria is an early marker of target organ damage 
in hypertension.
4 
Various studies have shown a prevalence rate of 
microalbuminuria ranging between 4.7% to 46% in essential 
hypertension. 
Hemodynamic load is the major determinant of albumin 
excretion  in persons with mild hypertension and no cardiovascular 
complications , whereas in subjects with more severe hypertension and 
associated target organ damage, augmented urinary loss is probably the 
consequence of glomerular damage.
5 
It has been proved that microalbuminuria is a risk factor for the 
development of clinical proteinuria, renal failure and increased 
cardiovascular mortalityin insulin dependent diabetes mellitus. The 
studies shows that the microalbuminuria also predicts development of 
proteinuria and decline in renal function in hypertension.
6 
Effective  diagnosis  and management  of hypertension is a 
crucial component of such efforts. High blood pressure  causes of 
kidney injury and in advanced stages, renal failure. 
Renal hypertension puts stress and increased pressure on the 
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kidney, and  a  major cause of end-stage renal disease. 
Hypertensive nephropathy refers to renal injury due to chronic 
elevated blood pressure.  
Additional complications often associated with hypertensive 
nephropathy nclude glomerular injury  resulting in proteinuria and 
haematuria
i
 
 
 
                                
 
 
 
 
Figure showing pathophysiology of hypertensive renal disease. 
People may have CKD but are not aware of it because they 
and diabetes, need to be assessed regularly and managed in line with 
established guidelines
ii
. 
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The appropriate evaluation and treatment of hypertension is 
crucial in caring for patients with CKD, as blood pressure not 
controlled can lead to decline in kidney function and faster 
development of cardiovascular disease, considered the foremost 
cause of death in CKD patients.  
As the prevalence of these risk factors associated to CKD  is 
growing in exponential  rate, a country cannot leave the burden of 
CKD unattended; therefore prevention, early detection, and 
treatment are the cost-effective strategy.  
Prevention of end stage renal disease (ESRD) by early 
detection and treatment is an critical point in reducing the need for 
renal transplant. 
Evaluation of hypertensive patients for the presence of CKD 
is critical as part of preventive care and treatment strategies.     
Measuring of the urinary albumin excretion have been used as a 
screening test for CKD in hypertensive patients.  
The normal rate of urinary albumin excretion is less than 20 
mg/day. Persistent of albumin excretion between 30 and 300 mg/day 
is termed microalbuminuria, while ,albumin excretion above 300 
mg/day is considered macroalbuminuria. 
 It has  been shown   that   microalbuminuria   represents  the 
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renal   involvement of  generalized vascular endothelial  damage
iii
,  
which is frequently seen in patients with established essential 
hypertension, and is a predictor  for cardiovascular and probably 
renal injury. 
Microalbuminuria is not only a simple but also an accurate 
method to detect a hypertensive patient at a high risk for 
cardiovascular and probably renal damage. 
National Kidney Foundation  recommend  combined  
screening for microalbuminuria and estimated GFR for all adult 
patients with CVD as well as  those with risk factors for CKD,   
such as diabetes, hypertension,  and high body mass index. 
Clustering microalbuminuria with other markers of 
endothelial function such as red cell distribution width (RDW) may 
contributes to the prediction of renal involvement  in hypertension. 
The RDW is a measure of the variation of red blood cell width. 
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AIMS AND OBJECTIVES 
 
 
1. To detect the presence of microalbuminuria and red cell 
distribution   width in patients with  hypertension. 
2. To study, the correlation of microalbuminuria and red cell 
distribution width in  patients on different stages of hypertension 
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REVIEW OF LITERATURE 
 
Historical review 
Though the disease has existed since antiquity, it became 
possible to recognize it only after the discovery of a devise to measure it. 
It was William Harvey and Lennaec who discovered 
circulation of blood in early 1600 and Stethoscope in 1819 
respectively. Vierordt a German scientist was the first person to invent 
an instrument that measures blood pressure on early1850s.  
Though  blood pressure measurement using this instrument was 
time consuming, he is considered the pioneer in formulating the 
principle behind the estimation of blood pressure, that is, by 
obliterating the pulse which is followed even today. 
It was Rivarocci who devised  auscultatory method of finding 
blood pressure . 
Ever since the discovery of the instrument, many studies have 
been done throughout the world and high-lightened the necessary for 
addressing the disease. 
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Definition 
The definition of hypertension is usually taken as that  level of 
pressure  associated with a doubling of long terms risk. Perhaps 
the bestoperational definition is “the level which the benefits (minus the 
risks and costs) of actionexceeds the risks and costs (minus the benefits) 
of inaction 
iv
 
As per the of JNC VII report on prevention, detection, evaluation 
and treatment of high B.P. 
v 
 
 
 
 
 
 
These definitions apply to adults who are not on  anti 
hypertensive agents and who are not acutely ill. When systolic and 
diastolic blood pressure fall into different categories, the higher 
category should be selected to classify the individual’s blood pressure 
status. 
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Optimal BP with respect to cardiovascular  risk is < 120 mm Hg 
systolic and < 80 mm Hg diastolic, based on the average of two or more 
readings taken at each of two or more visits after an initial screening. 
Guidelines for measurement of BP 
vi
 
“Patient conditions 
Posture: 
For patients older than 65 years, diabetic or is receiving 
antihypertensive therapy, check for postural changes by taking 
readings after 5 min of supine, then immediately 2 min after standing. 
For routine follow up, a patient should sit quietly for 5 min with 
arm bared and rested at the level of the heart and the patient comfortably 
resting in a chair. 
Circumstances: 
Patient should have no coffee and should not have smoked with 
in 30minutes preceding the readings. 
Patient should have ingested no exogenous adrenergic 
stimulants(e.g.phenylephrine  in nasal decongestants). Readings should 
be obtained in a quite, warm setting.” 
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“Equipment 
Cuff size:  
The bladder should encircle at least 80% of the circumference and 
cover 2/3
rd
 of the length of the arm; if it does not, place the bladder over 
brachial artery. A too small bladder may cause falsely high readings. 
Monometer: Use a mercury, recently calibrated aneroid, or validated 
electronic device. 
Stethoscope: To avoid interference the bell of the stethoscope should be 
used and the cuff has be placed with the tubing at the top. 
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Technique 
Number of readings 
On each occasion, take at least 2 readings, separated by as 
much time as is practical; if readings vary by > 5 mm of Hg, take 
additional readings until two readings are close.” 
Performance 
Position the bell of the stethoscope over the brachial artery 
(confirm the bell setting by lightly tapping it) and rapidly inflate the 
cuff to 20-30 mm Hg above the systolic blood pressure determined by 
palpatory method [to detect an auscultatory gap]. 
Deflate the cuff at a rate of 2 mm Hg / second, listening for phase 
1 and phase V phase IV for children] Korotkoff sound. Phase 1 is the 
first appearance of any sound and phaseV at the disappearance of the 
sound which is the DBP in adults.  
Listen for 10-20 mm ofHg below phase V for any further sound, 
then deflate the cuff rapidly and completely and allow the subject to rest 
for at least 30 seconds. 
If Korotkoff sounds are weak, then ask the patient to raise the 
arm and open & close the hand for 5-10 times, then inflate the bladder 
quickly. 
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Recordings 
Note the pressure, patient positions, the arm, cuff size [e.g. 
140/90 mm Hg, seated, right arm, large adult cuff]” 
MECHANISMS OF CONTROL OF ARTERIAL PRESSURE 
Knowledge of mechanisms depends mainly on laboratory data, 
which rely more on measurements of mean arterial pressure than on 
systolic or diastolic pressure. 
Mean arterial pressure is not the midpoint between systolic and 
diastolic pressure but it is approximated by adding 1/3rd of the pulse 
pressure to the diastolic pressure.  
It is the result of variable interactions between the ejection blood 
flow from the left ventricle, the arterial blood volume and the 
capacitance, diameter and physical properties of the entire arterial tree, 
from aorta to terminal arterioles, collectively known as arterial resistance. 
In general terms, biological control systems tend to operate at 3 
levels. 
 By rapid response through nervous system 
 By delayed response operating humorally 
 By long-term adaptive response which may involve 
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modification of the composition and behavior of any or the all 
body systems. 
Each of these 3 involves a sequence of control systems, so that 
when one fails a backup system comes into operation at a cruder level. 
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Cardiac output and peripheral resistance 
Variations in arterial pressure therefore represent variations in 
the product of cardiac output and peripheral resistance. In practice 
peripheral resistance is never directly  measured, it is measured from the 
observed quantities, cardiac output and mean arterial pressure as given 
by Frank’s formula. 
Resistance = mean pressure (mm hg) x 1330 / Cardiac output (ml 
per secs). 
Regulation of cardiac out put 
Altering responses from the cerebral cortex and feed back 
responses in the brain stem mainly regulate cardiac output in man. 
These operate on heart rate, accelerating it through the sympathetic 
nerve and decreasing it through the vagus nerve. 
Starlings Law of heart 
Increased diastolic filling lengthens heart muscle fibers and thus 
increases stroke output. Increased venous return is a main determinant of 
cardiac output, but operates for short of the break down point of raised 
diastolic filling. Output rises in anticipation of exercises through CNS 
pathways originating in the cortex, and during exertion through 
accelerated venous return, caused by the pumping action of 
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muscles. Peripheral resistance is reduced by dilatation of the smaller 
arteries and arterioles. 
All these mechanisms operate synchronously to produce a strictly 
linear relation between rising cardiac outputs and rising oxygen uptake 
during exercise, though arterial pressure rises in anticipation of 
exercises, the rise is much smaller than the rise in heart rate. 
Cardiac output is probably normal in early and middle stage 
hypertension and is maintained up to end stage hypertension, when it 
falls. 
FRANK STARLING LAW 
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Autonomic control of arterial pressure 
Peripheral resistance and cardiac output both are mainly 
dependent on autonomic nervous system control. 
All autonomic reflex pathways involve the CNS at least at spinal 
levels and these cannot be isolated from their higher nervous connections 
in life. 
Sympathetic adrenal system 
From the functional point of view, the motor or cells of the 
sympathetic system are situated in the paravertebral cervical and 
preaortic abdominal ganglia. The cell of the lateral horn is the connector 
cell. The afferents for sympathetic reflexes come from all parts of the 
body. Many of the reflexes pass through the vasomotor center of the 
medulla, but in some it is through spinal, notably those excited by a 
deep breathe and those from full bladder. This is equally true with the 
adrenal medulla, which releases its effector hormones in the same way 
as the ganglion cells and the post ganglion axons of the sympathetic 
nerves. The effects of stimulating sympathetic adrenal system are 
broadly to reduce blood flow through the skin, gut, and to a smaller 
extent to the kidneys and to increase flow through the voluntary 
muscles and heart muscle. Blood flow to brain  remains more or less 
constant.  
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The cerebral arteries are poorly innervated and are poorly  
responsive to adrenaline . 
Total blood flow at rest is 5.8 lts/ min of which 750 ml (13%) 
goes to the brain, 1400 ml (24%) to the gut, 1100 ml (19%) to kidneys, 
250 ml (4%) to the heart and 1200 ml (21%) to the voluntary muscles. 
Blood flow during exercise increases by 4 fold to 25 lts / min and brain 
flow remains the same. Gut flow falls nearly by 5 fold, kidney flow 
falls four by folds and voluntary muscle flow increases by 18 times. 
Baroreceptor reflexes 
The sympathetic adrenal system is a final common pathway 
both for changes initiated consciously at cortical level (fear, anger and 
planned adventure) and for vascular reflexes that remain intact in the 
spinal animal. The most important vascular reflexes are those of 
baroreceptors. 
At the origin of internal carotid arteries and scattered within the 
aortic arch, there are specialized stretch receptors arranged in layer 
between the outer coats of these vessels. Stimulation of these 
receptors either by stretching or by direct electrical stimulation, 
results in a fall in arterial pressure through reflex slowing of heart 
and vasodilatation of skin, voluntary muscles, gut and kidneys. This  
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reflex arc passes from the baroreceptor by afferent nerves to the 
brainstem and hence through the vagus to the heart. The reverse 
response, raises pressure by sympathetic arteriolar constriction and 
adrenaline release. 
The renin angiotensin system 
Renin is an enzyme produced from cells surrounding the afferent 
arterioles of  the  renal glomeruli [the juxta glomerular apparatus]. It acts 
on a plasma substrate produced in the liver, to yield angiotensin, the most 
potent vasoconstrictor. 
The main stimulus for renin release from Juxtaglomerular 
apparatus is low sodium intake [10 m mol / day] or increased sodium 
output as in use of diuretics.  
Renin release is depressed by high sodium intake. As well as its 
peripheral role in arteriolar constriction, angiotensin acts centrally on 
brain stem, causing increased sympathetic discharge The renin 
angiotensin system also controls the release of aldosterone which in turn 
controls sodium output from the renal tubules and hence blood volume.  
Aldosterone secreting tumors of adrenal gland are rare cause of 
hypertension.                      
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Integration of pressure control in CNS 
In man, none of the mechanisms described can operate 
independently of central control in the integrative centers of brain 
stem, which include a pathway from the vasomotor center, down the 
spinal cord to the sympathetic preganglionic nerves in the lateral horn 
of the gray matter. It is an adrenergic system, which operates to 
raise pressure. 
There is probably also a brain stem inhibitory system, also 
adrenergic, with an uncrossed pathway from the brain stem to the 
vagus. These brainstem centers receive feedback information from the 
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viscera, and respond within wide limits to information from the cortex. 
The effects of actual or anticipated maximal exertion on 
arterial pressure are striking. Mental excitement is probably a 
commoner cause of sympathetic activation,tachycardia, and raised 
arterial pressure. Stress in the form of mental exertion such as mental 
arithmetic increases heart rate by 30% and arterial pressure by 10%. 
Evidence of the normally predominant control of pressure by the brain 
is the fall in pressure during sleep. This accounts to about 20% in both 
systolic and diastolic pressure, compared with mean waking pressure. 
Fully automotive portable recorders attached to intra-arterial 
catheters made all these measurement on which this estimate is based. 
Association of hypertension with other conditions 
Obesity 
Hypertension is more common among obese individuals and 
probably adds to their increased risk of developing IHD. In the 
Framingham study adiposity as measured by subscapular skin fold 
thickness was the major controllable contribution to hypertension. 
Even small amounts of weight gain are associated with a marked 
increase in incidence of hypertensive and coronary mortality. 
Children seem particularly vulnerable to the hypertensive effects 
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of weight gain. 
Therefore avoidance of childhood obesity with the hope of 
avoiding subsequent  hypertension seems to be important. 
Sleep apnea: one of the contributors to the hypertension in obese people 
is sleep apnea. 
Snoring and sleep apnea are associated with hypertension, and 
this in turn may be induced by increased sympathetic activity and 
endothelin release in response to hypoxemia during apnea. 
Physical inactivity 
Physical fitness may help to prevent hypertension and persons 
who are already  hypertensive may lower their blood pressure by regular 
isotonic exercise 
Alcohol intake 
Even in small quantities, alcohol may raise blood pressure. In 
large quantities alcohol may be responsible for a significant number of 
cases of hypertension. 
 In all studies of this problem, some have found a linear, 
progressively increasing level of BP with increasing consumption of 
alcohol, most report a threshold effect, where as some find lower levels 
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of blood pressure among those who drinks 1-2 ounces a day than 
among those who do not drink at all. 
The reduction in coronary disease in persons who ingest small 
quantities of alcohol beyond any effect on blood pressure, may reflect a 
greater mobilization of tissue free cholesterol for hepatic removal and 
excretion. The pressure effect of alcohol primarily reflects on increase in 
cardiac output and heart rate possibly as a consequence of increased 
sympathetic activity. 
Smoking 
Cigarette smoking raises blood pressure, probably through the 
nicotine induced release of nor epinephrine from adrenergic nerve 
endings. The increased risk of stroke among cigarette smokers probably 
involves an acute fall in cerebral blood  flow. When smokers quit 
smoking, a trivial rise in blood pressure may occur,  probably 
reflecting a gain in weight. 
Diabetes mellitus 
Hypertension is present in about 2/3rd of patients with diabetes 
who have the associated intracapillary glomerulosclerosis described by 
KIMMERSTEK and WILSON and prevalence of hypertension in the 
overall population of diabetes has increased. The co-existence of 
diabetes and hypertension almost redoubles the already high rate of 
 29 
cardiovascular mortality seen in non-diabetic hypertensives. 
Diabetics are also susceptible to special problems 
associated with antihypertensive therapy. Diuretics may exacerbate the 
carbohydrate intolerance probably by inducing potassium deficiency. 
Those in whom the condition is brittle and who are prone to 
hypoglycemia may have difficulties with beta-blockers, ACE 
inhibitors are effective in reducing high intraglomerular pressure. 
Polycythemia 
Polycythemia Vera is frequently associated with hypertension. 
More common is a pseudo or stress Polycythemia with a high 
haematocrit and increased blood viscosity but contracted plasma volume 
as well as normal red cell mass and serum erythropoietin levels. 
Gout 
Hyperuricaemia is present in 25-50% of individuals with 
untreated primary hypertension, about 5 times the frequency 
found in normotensive individual. 
Hyperuricaemia likely reflects decreased renal blood flow, 
presumably a reflection of nephrosclerosis, when diuretics are used, uric 
acid level rises further. 
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Types and causes of hypertension 
vii
 
viii
 
ixx
 
A. Systolic and diastolic hypertension 
1. Primary, essential or idiopathic 
2. Identifiable causes [secondary hypertension] 
i.Renal 
A. Renal parenchymal diseases 
a. Acute glomerulonephritis 
b. Chronic nephritis 
c. Polycystic disease 
d. Diabetic nephropathy 
e. Hydronephrosis 
B. Renovascular disease 
a. Renal artery stenosis 
b. Intrarenal vasculitis 
C. Renin producing tumors 
D. Primary sodium retention [Liddle’s Syndrome, Gordon’s Syndrome] 
ii. Endocrine disorders 
a. Acromegaly 
b. Hypothyroidism  
c. Hyperthyroidism 
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d. Hypercalcemia [hyper parathyroidism] 
e. Adrenal disorders f. Extra adrenal chromaffin tumors 
g. 11-hydroxy steroid dehydrogenase deficiency or inhibition 
  [licorice] 
h. Carcinoids 
i. Exogenous hormones 
 Cortical disorders 
 Cushing syndrome 
 Primary aldosteronism 
 Congenital adrenal hyperplasia 
 Medullary tumors [pheochromocytoma] 
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 Foods containing tyramine and monoamine oxidase inhibitors. 
 Coarctation of aorta and aortitis 
 Pregnancy induced hypertension 
Neurologic disorders 
 Increased intra cranial pressure 
  1. Brain tumor 
  2. Encephalitis 
 Sleep apnea 
 Quadriplegia 
 Acute porphyria 
 Familial dysautonomia 
 Lead poisoning 
 Guillian barre syndrome 
B. Systolic hypertension 
1. Increased cardiac output 
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 Aortic regurgitation 
 Thyrotoxicosis 
 Patient ductus arteriosis 
 Arteriovenous fistula 
 Hyper kinetic circulation 
 Paget’s disease of bone 
 Beriberi 
2. Decreased compliance of aorta [atherosclerosis] 
Clinical features of hypertension 
The majority of patients with hypertension have no specific 
symptoms referable to blood pressure elevation and will be identified 
only in the course of physical examination 
Headache: is characteristic only for severe hypertension which is 
commonly localized to occipital region. It is usually present when 
patient awakens in morning and subsides spontaneously after several 
hours. 
Other possible related complaints include 
♦ Dizziness 
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♦ Palpitation 
♦ Easy fatigability 
♦ Impotence 
Complaints referable to vascular disease include: 
♦ Epistaxis 
♦ Haematuria 
♦ Blurring of vision due to retinal changes 
♦ Dizziness due to TIA 
♦ Angina and dyspnoea due to cardiac failure 
Clinical evaluation of essential hypertension  
A strong family history of hypertension along with the 
intermittent finding of elevated pressure in the past favours the diagnosis 
of hypertension. 
Elicit risk factors: Smoking, Diabetes, Renal disorders. 
Asses patients’ life style: Diet, physical activity, family status, and 
work. 
Physical examination 
Starts with general appearance: Round face and truncal obesity – 
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Cushing  syndrome 
If muscular development of upper extremities is out of proportion 
to lower limit-Coarctation of Aorta. 
Compare the BP and pulse in both extremities, in supine and 
standing 
Measure patients height and weight 
Fundus examination because this provides clues to the duration 
and prognosis of  hypertension. 
Palpation and auscultation of carotid arteries for evidence of 
stenosis or occlusion 
Examination of cardia 
 For evidence of left ventricular hypertrophy and cardiac 
decompensation 
 For left ventricular lift 
 For 3rd and 4th heart sounds 
Examination of lungs 
 For pulmonary rales. 
 Extra cardiac murmurs and palpable collateral vessels as seen in 
Coarctation of aorta. 
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Examination of abdomen 
 Auscultation for bruits originating in stenotic renal arteries, these 
have diastolic components, best heard just right or left of midline, above 
umbilicus 
 Palpation for aneurysms and enlarged kidneys 
Examination of extremities for oedema 
 Search for evidence of previous Cerebro vascular disease 
Laboratory investigations 
 Urine for protein, sugar, and blood,  
 Microscopy.  
 Complete blood count with RED CELL DISTRIBUTION WIDTH 
 Serum creatinine, blood urea, serum electrolytes 
 Fasting blood glucose 
 Total cholesterol 
 ECG 
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Microalbuminuria as a marker for cardiovascular disease in 
subjects with hypertension 
The main function of the Kidneys,  the major excretory organ of 
the body. is filteration of the blood and the removal  toxic molecules and  
products of metabolism (example; creatinine and urea) and also,if 
present, any extra fluid for the body to maintain appropriate blood 
volume . 
The kidney also does reabsorbing water and necessary 
important  molecules including  electrolytes (example; sodium and 
potassium) and proteins. 
Blood filtration occurs in the nephron, w h i c h  a r e  the 
functional unit of the kidney.  
Normally,in each of the kidneys there are more than a million 
nephrons. Blood filtration occurs in the tubules and glomerulus in each 
nephron. Filtration membrane is present in the glomerulus which 
consisting of three layers: 
The endothelium,  
The epithelial podocyte  
The basement membrane. 
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  The glomerular filtration membrane permits certain blood 
substances to pass through it in order to reach the tubular system 
which consists of four parts:  
The proximal convoluted tubule, 
Loop of Henle,  
Distal convoluted tubule  
And collecting duct 
In the renal tubular system, most of reabsorption process occurs. 
Glucose and plasma proteins are readily  reabsorbed in the proximal 
tubule . In the loop of Henle, concentration of urine takes place through 
reabsorption of  water. Sodium and potassium ions regulation takes  place 
in distal tubules. Final reabsorption of ions takes place in the collecting 
duct. 
The flows of blood to the kidney is through the renal artery. 
The renal artery then branches into the segmental arteries which 
further divides to different lobular arteries . These arteries further branch 
into interlobular arteries that divide to form afferent and efferent 
arterioles The afferent arterioles are the one which is responsible for 
supply of blood to the glomerulus while removal of blood from of the 
glomerulus is through efferent arterioles. 
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B y  vasoconstriction or vasodilation  both t h e  afferent and 
efferent arterioles plays avital role in regulating the pressure in 
glomerular capillary.  
Protein reabsorption 
Serum proteins play major roles in the body including 
transporting essential molecules such as hormones, vitamins, lipids, 
minerals and exogenous substance such as drugs.  
Proteins also maintain the oncotic pressure between the plasma 
and interstitial space, and are involved in the synthesis of enzymes 
and other substances. 
Proteins in the blood can be divided into, for example, carrier 
proteins such as albumin, immune system proteins such as 
immunoglobulin and acute phase proteins such as CRP. 
The most abundant serum protein is albumin, accounting for 
60% of serum protein and with a concentration of 3.4 - 5.4 g/dL. 
Albumin is a highly soluble  single polypeptide which consists of 585 
amino acid sequence.  
Each day, 9 - 12 g of albumin is produced by the liver. More than 
70% of oncotic colloid pressure is controlled by albumin. 
Levels of albumin are affected by factors including endogenous 
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molecules such as insulin and cortisol. 
As mentioned earlier, kidney reabsorption of albumin and other 
proteins that pass the glomerular filtration membrane occurs in the 
proximal convoluted tubule. This reabsorption process is achieved 
by receptor-mediated endocytosis.  
A receptor complex called megalin-cubilin is involved in the 
endocytosis process. The reabsorption process can be summarised as 
follow: albumin binds to the megalin-cubilin receptor complex in the 
apical plasma membrane. 
After that, an adaptor molecule binds to the tail of the receptor 
complex to help the internalisation of the ligand-receptor complex (Cui 
et al., 1996). Once the internalization process occurs, an endocytic 
vesicle transports the formed complex to the endosomal  compartment 
where the protein complex dissociates by vesicle acidification. 
Albumin then undergoes degradation in the lysosome to its original 
amino acids which return to the blood stream. 
Kidney 
xi
 
 Proteinuria and microscopic haematuria takes place as a result of 
lesions of glomerulus and also more or less 10% of  deaths caused by 
hypertension are attributed to renal failure.  
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Blood loss in hypertension occurs from renal lessions. 
Microalbuminuria 
Microalbuminuria has recently been considered, to be an early 
marker of widespread vascular damage ,that is, target organ damage in 
essential hypertension.
xii,
xiii
 
Since Microalbuminuria is also associated with a constellation 
of metabolic and non-metabolic risk factors, it m a y  indicate the 
presence of  more generalized damage to microvascular structures in 
hypertensive patients.  Hypertensives who are found to have  
microalbuminuria   are  also noted  having a greater  prevalence of 
disease of coronary artery  and cerebrovascular b e d s  when compared 
with their normoalbuminuric counterparts Microalbuminuria might be 
an early marker of renal involvement by systemic disease among 
which hypertension is one of the important cause.
xiv
 
On  examining the relation between microalbuminuria  and to 
renal structural changes, it was noted that increase in albumin excretion 
was present with hypertension, or decrease in creatinine  clearance,  
were associated with already established abnormalities involving 
glomerular structures. 
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It includes, increase in  the thickness of glomemular basement 
membrane and mesangium enlargement This implies that 
microalbuminuria is not only a predictor of renal involvement in 
hypertension but rather considered a marker of early nephropathy. 
Hypertensives hav ing  microalbuminuria manifest increase in 
levels of blood pressure, especially at night and higher va lue  o f  
serum cholesterol, TGL and uric acid than patients with normal urinary 
albumin excretion.
xv
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Level of high-density lipoprotein on the other hand was lower 
in patients with microalbuminuria than in those without it. Patients 
with microalbuminuria showed a greater prevalence of insulin 
resistance and thicker carotid arteries than patients with normal urinary 
albumin excretion.
xvi  
Rate of creatinine clearance in patients with microalbuminuria 
decreased  more than that in those with normal urinary albumin 
excretion. In conclusion, studies suggest that hypertensive patient 
manifesting microalbuminuria harbor variety of biochemical and 
hormonal derangements with  adverse impact, which result in 
hypertensive patients having a greater incidence of cardiovascular 
events and a higher fall of  renal function than patients with  urinary 
albumin excretion at normal quantity. 
xvii
 
In 1960’s the first description of microalbuminuria was made in 
patients who were newly diagnosed with type 2 diabetes in the Diabetes 
detection study in Bedford, in United kingdom , by the use of a new 
more sensitive assay for urinary albumin.
xviii  
Urinary albumin excretion w a s  f o u n d  t o  correlate 
significantly with blood Pressure, more specifically the systolic blood 
pressure. 
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It lead to the observation that  hypertension and  hyperglycemia 
may both combine to increase the degree of albuminuria.  
It is now widely accepted that microalbuminuria signifies a 
more generalized vascular problem, not restricted just to the renal 
microcirculation, bu t  is itself independently associated with more 
extensive vascular pathology. It is observed that, microalbuminuria is 
present in a significant proportion of the non-diabetic population, 
especially in association with systemic arterial hypertension, and it 
appears to predict the incidence of cardiovascular disease. 
xix
,
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,
xxi
,
xxii
,
xxiii
,
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,
xxv
 Studies now shows that, the renal architecture 
is better preserved by antihypertensive treatment and thus function 
of renal sysem is better maintained on long term follow up. 
There is now a consensus to treat patients with 
microalbuminuria with Angiotensin converting enzyme inhibitors or 
alternative blood pressure lowering treatment even in the presence of 
so-called normal blood pressure. 
xxvi
, 
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Epidemiology of Microalbuminuria in Essential Hypertension 
Between 2 and 10% of the adult non-diabetic population has 
been found showing persistent microalbuminuria, with a higher 
frequency in certain ethnic groups such as Afro-Caribbean’s, Afro-
Americans, Pacific islanders and Australian Aborigines. 
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Patients having essential hypertension shows a positive 
proteinuria in between 4 and 16% of cases, however the prevalence of 
microalbuminuria is reported with wider variation in the range of  5 and 
37%. Microalbuminuria is found to be more common in the older 
population and in males.  
Both microalbuminuria and overt proteinuria are noted to be 
associated with an Hypertrophied left ventricle, myocardial ischaemia, 
thickness of carotid artery and overall cardiovascular morbidity and 
morality. Recent studies suggest that microalbuminuria is an 
independent risk factor for cardio vascular injury.
xxvii
 
xxviii
 
Proteinuria even  present in small quantities have found to be 
toxic to nephrons. In study it has been found  that persons  with 
microalbuminuria even at levels too low to detect with standard 
dipstick tests have an increased risk for preclinical nephropathy and 
also cardiovascular morbidity and mortality. 
xxix
 
DEFINITION OF MICROALBUMINURIA 
The median daytime excretion of albumin, which is the major 
plasma protein  is 4 to 6 g /minute in population – based studies, 
and the 90th percentile is about 20g/minute or 30 mg/ 24 hours. 
The standard urinalysis dipstick can detect albumin only at 
levels greater than 30mg/ dl – 300mg/ 24hours if the output is 1L, 
anything above this level of excretion is called macroalbuminuria.  
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Microalbuminuria may  be  cited  as the range in between: 
urinary excretion of albumin of 20 to 200 g/minute or 30 to 300mg/ 24 
hours. 
xxx
 
Diagnostic definition of normo-, micro-and macroalbuminuria 
xxxi
 
 Condition 
 
24-h urinary 
albumin 
 
excretion rate 
 
Over night 
urinary albumin 
 
excretion rate 
 
Albumin: creatinine 
ratio* 
Macroalbuminuria 
(Overt nephropathy) 
 
> 300 mg/day > 200g/min > 25mg/mmol 
Microalbuminuria 
 
30-300mg/day 
 
20-200g/min 
 
2.5 –25mg/mmol (for 
men) 
 
3.5-25 mg/mmol (for 
women) 
 
Normoalbuminuria 
 
< 30mg/day < 20g/min 
< 2.5 mg/mmol (for 
men) 
< 3.5mg/mmol (for 
women) 
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The concentrations of albumin and creatinine in the first urine 
sample in the morning correlate very well with those in 24 hours 
sample, and an overnight albumin-to creatinine ratio greater than 2mg/ 
mmol predicts urinary albumin excretion in the range of 
microalbuminuria with high sensitivity and specificity.  
Thus, it is not always necessary to obtain a 24-hours urine 
sample to have a reliable evaluation. 
Furthermore, the concentration of albumin in these early urine 
samples is highly predictive of morbidity and mortality in high-risk 
population.  
Mechanism of association between microalbuminuria and 
hypertension 
xxxii
 
There are at least three ways by which increased urinary 
albumin excretion rates Can occur: 
 Increased intraglomerular pressure; 
 Glomerular injury causing disruption of the glomerular filtration 
barrier; 
 Tubular damage cumulating in loss of normal reabsorption 
of   filtered albumin . 
 
 48 
Increased intraglomerular pressure 
Pressure within the glomerulus is determined by the balance 
between the  Equilibrium between constriction and dilatation of the 
afferent and efferent  arterioles of the glomerulus. Arteriolar tone is 
regulated by a range of mechanisms and pressor/ depressor substances. If 
auto regulatory function of these arterioles is defective, it results in 
raised  intraglomerular pressure. 
For example, the afferent arteriole normally protects the 
glomerulus against raised systemic blood pressure by 
vasoconstriction. Conversely, vasoconstriction of the efferent arterioles 
will tend to increase intraglomerular pressure. 
Many studies, both in humans and animals, suggest that loss 
of normal auto regulatory function is likely to be involved in 
development of raised intraglomerular pressure leading to protein 
leakage and renal injury. The mechanisms include  increased 
sympathetic nervous system activation, hyperinsulinemia, decreased 
production  of vasodilator hormones and activation of the rennin- 
angiotensin system.  
Interestingly,  ACE inhibitor drugs which are thought to act in part 
by causing relaxation of the efferent  arteriole have, been associated with 
reduction in protein leakage and renal protection in  both patients with 
and without diabetes. 
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It is also possible that systemic hypertension is directly 
responsible for the renal haemodynamic changes facilitating protein 
leakage. Systolic blood pressure has been  particularly strongly 
correlated with development of microalbuminuria. 
Changes in glomerular barrier filtration 
Selectivity of the basement membrane of glomerulus is 
important to normal glomerular function and may be deranged in 
association with microalbuminuria. In patients with diabetes, glycation 
of long- lived tissue proteins may cause loss of Polarity causing albumin 
loss. This association between microalbuminuria and impairment of 
charge selectivity has recently been shown in individuals with no 
diabetes. 
These abnormalities have been associated with vascular 
endothelial and vascular  permeability factors. 
One hypothesis is that microalbuminuria is the renal manifestation 
of generalized  vascular endothelial dysfunction, which could explain 
the strong link cardiovascular  disease and may have a genetic basis. 
In support of this, it has been reported that, the  microalbuminuria: 
 Is associated with reduced size and charge selectivity of the 
glomerular vessel wall in healthy people 
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 Is an independent markers of systemic vascular albumin leakage 
 Correlates with von willebrand’s factor antigen, factor VIII 
hyperactivity,  endothelial cell damage. 
 Atherosclerosis per se is also associated with renal and systemic 
vascular leakage. 
The Orion diagnostic urinary albumin assay is an 
immunoturbidimetric, diagnostic assay for quantification of albumin 
in human urine by means of clinical chemistry analyzer. The original 
diagnostic microalbuminuria assay is based on the measurement of 
immunoprecipitation in liquid phase. Antibodies against human albumin 
are added to an aliquot of patient urine and Reaction buffer. The 
antibodies undergo an agglutination  reaction with albumin in the urine 
resulting in an increase in the turbidity of the mixture. 
Turbidity is measured by using a clinical chemistry analyzer at 
a wavelength of ca.405nm. Microalbuminuria, cat. No. 67352content. 
The reagents contains sodium azide as preservetive, Store at 2…8c. 
The calibrators have been standardized using the IFFC preparation 
CRM 470.as primary reference material. 
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Additional Reagents 
 0.9%Nacl solution or 0.01mPBS (PH 7.2) in case the 
application needs a zero calibrator. 
 0.9%Nacl solution for sample dilution, in case the concentration 
obtained exceeds the measurement range. 
Assay procedure 
Sample preparation: 
Microalbuminuria assay is performed in urine. Adding 
preservatives is not  recommended.  If the test cannot be performed 
immediately, the urine may be stored at 2…8c for 14 days. Urine 
samples should not be frozen. Turbid samples can be  centrifuged 
before assaying (e.g. 2000 g for 15 min). 
A 24 - hour urine sample is needed On day 1,urinate into the toilet 
upon arising in the morning  Collected all subsequent urine (in a 
special container) for the next 24hours. 
On day 2, urinate into the container in the morning upon arising 
Cap the container, label the container with patient name, the date, the 
time of completion, and return it as instructed  Deliver it to the laboratory 
or your health care provider as soon as possible upon completion. 
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Use 12-hour night collection or 24 hours collection. Centrifuge 
urine samples. Screen these samples using an albumin test strip. If the 
result is negative (approx, below 300mg/1) analyse the samples 
undiluted. If the result is positive, dilute the sample e.g.,1:5 (1+4) with 
0.9% NaCI solution to obtain a concentration within measuring range. 
Multiply the results obtained by 5. 
Antiserum reagent dilution  
Dilute albumin antiserum with reaction buffer according to the 
instructions for instrument.  
Calibration curve: The references are ready-to-use The 
concentrations of references and control are marked on the 
bottle. Measurement range; Ca .8-160mg/1 Use urine Albumin control 
(cat. No.67352) for checking the level. 
The clinical chemistry analyser displays albumin concentration as 
mg/l (=g/ml). 
The albumin excretion rate for a timed urine sample (g/min) 
can be calculated using  the following formula: 
(Total urine volume (ml) / Collection period (min) ). 
Urine albumin value (mg/’) = albumin excretion rate (g/min) ] 
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Normally less than 150mg of protein per day (or 10mg per 
deciliter) are excreted in the urine. The proteins are derived from plasma 
and the urinary tract. About one –third of the protein is comprised of 
urine albumin, about one- third small globulins, and about one- third is 
Tamm-Horsfall protein (a glycoprotein that is secreted by distal 
tubular cells).  
Most of the filtered proteins are normally reabsorbed by the 
proximal tubular cells; so little or no protein normally appears in the urine 
Concomitant factors of microalbuminuria 
Microalbuminuria and serum lipids:
xxxiii 
In patients with essential hypertension, the combined presence 
of microalbuminuria and hyperlipidemia is frequent, and greater  
levels of urinary albumin excretion correlate significantly with higher 
serum levels of  TGL   and apolipoprotein B and lower serum levels of 
high- density lipoprotein (HDL) cholesterol. Using multiple regression 
analysis, it is observed that lipoprotein (a)  was among several variable 
that correlate better with microalbuminuria Also  the urinary loss of 
protein may cause increase in serum lipoprotein levels. More over, some 
studies have indicated that even loses of small amounts of albumin in the 
urine may be associated with substantial alterations in serum lipoprotein 
levels in patients with diabetes. 
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An alternative explanation for the association between 
microalbuminuria and hyperlipidemia is that the hyperlipidemia causes 
renal damage and the increase in urinary albumin excretion. 
xxxiv
 
Microalbuminuria, Insulin resistance and Hyperinsulinemia in 
Hypertension: 
Several investigators have described the presence of insulin 
resistance and hyperinsulinemia in a substantial number of patients with 
essential hypertension. Several  lines of evidence also suggest that, 
hypertensives patients with hyperinsulinemia excrete  greater amount of 
urinary albumin, as the presence of increased urinary albumin 
excretion in subject without diabetes predicts the future development of 
NIDDM. 
 Thus, microalbuminuria can be considered a manifestation of the 
metabolic derangements that  predispose to NIDDM 
Microalbuminuria and cardiovascular disease:  
Also  increase in urinary albumin excretion is associated with an 
increased incidence of cardiovascular  complications and the morbid 
events such as left ventricular hypertrophy, myocardial ischaemia and 
hypertensives retinopathy.  
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The predictive value of microalbuminuria  persists even when 
the data are corrected for age, sex, and obesity and levels of blood 
pressure. Some studies have showed that an increase in urinary 
albumin excretion also  manifested an increased thickness of the 
coronary artery, a recognized marker of urinary  albumin excretion 
atheroslcersis. 
xxxv
 
Microalbuminuria and endothelial dysfunction co-exist in patients 
with essential hypertension. In many studies it was found that Von-
willebrand’s Factor (VWF)concentrations are higher in 
hypertensives patients with microalbuminuria than in patients without 
microalbuminuria.  
Albuminuria in essential hypertension may reflect systemic 
dysfunction of  vascular endothelium, a structure intimately involved 
in permeability, hemostasis, fibrinolysis and blood pressure control. 
This stepwise logistic regression analysis showed  that urinary albumin 
excretion was the most important independent predictor for  
cardiovascular complication, followed by diastolic blood 
pressure and serum cholesterol. 
STUDIES SHOWING RELATIONSHIP BETWEEN 
MICROALBUMINURIA AND HYPERTENSION 
There are several studies, showing strong relationship between 
microalbuminuria and essential hypertension. 
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In one study it was shown that, “ prevalence of 
microalbuminuria among the  essential hypertensives was 21.5% in 
hypertensives subject. Microalbuminuria was seen  more in patients 
with severe disease and was significantly influenced by the disease 
duration.” 
In another study it was showed  –“prevalence of 
microalbuminuria was 30% among essential hypertensives, with higher 
prevalence of vascular complications and longer duration of HTN in 
microalbuminurics.”  
Also “prevalence of microalbuminuria was 37.5% in patients 
with essential HTN and showed a positive correlation with the severity 
of HTN and thus may be an early marker for endorgan damage 
susceptibility.”39. 
 In a study, it has shown “ microalbuminuria is an early marker 
of preclinical brain damage in essential HTN and may therefore be 
useful for identifying patients as high risk for cerebral and 
cardiovascular events, for whom preventive therapeutic measures are 
advisable.”  
In a study “the systolic BP, mean arterial BP and pulse pressure 
values were significantly higher in the microalbuminuric than the 
normoalbuminuric hypertensive cases.” 
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“Hypertensive  with increased  microalbumin  in  urine manifest 
a variety of  derangements with pathogenic potential, which results 
in  greater incidence of cardiovascular events and deterioration of  
renal function than  patients with normal urinary albumin excretion.”  
“Microalbuminuric hypertensive patients showed signs of 
early target organ damage as compared to normoalbuminuric 
hypertensive patients and normal subjects, namely grater left ventricular 
mass indices and increased wall thickness of  common  carotid arteries as 
well as higher intra renal vascular resistance.”40 
In a study it has showed “that more number of patients with 
microalbuminuria with essential hypertension had LVH 
(42.3%Vs.12.2%), severe hypertensive retinopathy (30.8%Vs 4.1%) and 
renal insufficiency (30.6%vs 0%) as compared to patients without 
elevated proteinuria.”41 
In another study it has showed “that prevalence of increased Intima 
Media  thickness was more among subjects with microalbuminuria when 
compared to subject  with normoalbuminuria and also VWF 
concentrations were higher in hypertensives patients with 
microalbuminuria than without.”  
“Elevated UAE has been found to be a predictor of cardiovascular 
disease and an increased susceptibility/vulnerability to end – organ 
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damage, among the essential hypertensives.42 and also that proteinuria 
among essential hypertensives appears to reflect  widespread vascular 
damage. 
In a study, it has showed “that microalbuminuria has been 
associated with  cluster of metabolic and non- metabolic risk factors, 
suggesting that it might indicated the  presence of generalized 
microvascular damage in patients with essential hypertension.”  
“Hypertensives with microalbuminuria manifest greater levels of 
blood pressure, particularly at night, and higher serum levels of 
cholesterol, triglycerides, and uric acid than patients with normal urinary 
albumin excretion.”  
Red cell distribution width (RDW)                                   
It is  measurement of the  variation  present  in  red blood cell size 
or its  volume. RDW is elevated when there is increase in variation of  red 
cell size (anisocytosis), ie, when elevated RDW is present , marked 
anisocytosis (increased variation in  red cell size) is expected to be 
present  on peripheral blood smear . 
RDW reference range is as follows: 
RDW-SD 39-46 fL 
RDW-CV 11.6-14.6% in adult 
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Reference ranges may vary depending on the individual laboratory 
and patient's age. 
 Red cell distribution width (RDW)  measures variability of red cell 
volume/size (anisocytosis). Depending on the types of hematology 
analyzer instruments, RDW can be reported statistically as coefficient of 
variation (CV) and/or standard deviation (SD), RDW-CV and/or RDW-
SD, respectively. RDW-SD (express in fL) is an actual measurement of 
the width of the RBC size distribution histogram (see the first image 
below) and is measured by calculating the width (in fL) at the 20% height 
level of the RBC size distribution histogram (see the second image 
below). This parameter is therefore not influenced by the average RBC 
size RDW-CV (express in %) is calculated from standard deviation and 
MCV as follows (see the third image below): 
RDW-CV (%) = 1 standard deviation of RBC volume/MCV x 
100% 
Of note, since RDW-CV is mathematically derived from MCV, it 
is therefore affected by the average RBC size (MCV). 
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RED CELL DISTRIBUTION WIDTH HISTOGRAM 
 
 
 
 
 
 
 
 
 
 
 
 
RED CELL DISTRIBUTION WIDTH STANDARD DEVIATION 
MEASUREMENT 
 
Specimen: 
       Whole blood, usually collected by venipuncture 
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Collection: 
         EDTA tube (purple/lavender top) containing EDTA  potassium 
salt additive as an anticoagulant (see image below) 
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METHODOLOGY 
 
Patients with hypertension of varying durations coming t o  
Royapettah Government Hospital were chosen as subjects For this 
study, during the period of April 2014 to September 2014. 
Inclusion criteria: 
Patients with essential hypertension coming to Government 
Royapettah Hospital 
 
 
 
 
 
Exclusion criteria: 
 Patients with severe anemia 
 Patient with acute blood loss 
 A total of 50 patients were studied. All subjects were 
investigated in detailincluding history of symptoms and signs 
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suggestive of target organ damage, duration of  hypertension, drug 
history, previous blood pressure recordings, complete urine analysis, 
complete blood count with Red Cell Distribution width, biochemistry 
(urea, creatinine, FBS), ECG, 24 hours urine for microalbuminuria 
estimation was done by Immune Turbidmetric assay. Red cell 
distribution width was measured using Auto Hematology Analyser 
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RESULTS 
TABLE 1  
CORRELATION  BETWEEN RCDW AND MICROALBUMINRIA 
RCDW MICROALBUMINURIA 
PRESENT                         ABSENT 
11 – 13 1 18 
13 – 15 24 7 
 
TABLE 2 
CORRELATION BETWEEN SYSTOLIC BLOOD PRESSURE  
AND  MICROALBUMINURIA 
MICROALBUMINURIA 
SYSTOLIC BLOOD 
PRESSURE 
PRESENT                                                
ABSENT 
<120 2 9 
120 – 139 2 8 
140 – 159 12 5 
>160 9 3 
 65 
TABLE 3 
CORRELATION BETWEEN DIASTOLIC BLOOD PRESSURE 
AND MICROALBUMINURIA 
DIASTOLIC BLOOD 
PRESSURE IN MMHG 
MICROALBUMINURIA 
PRESENT           ABSENT 
<80 4 15 
>80 21 10 
 
TABLE 4  
 CORRELATION BETWEEN MICROALBUMINURIA AND 
GENDER 
 
SEX 
MICROALBUMINURIA 
 
PRESENT                          ABSENT 
MALE 16 20 
FEMALE 9 5 
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TABLE 5 
CORRELATION BETWEEN MICROALBUMINURIA AND AGE 
AGE yrs MICROALBUMINURIA 
PRESENT                                      ABSENT 
<50 3 13 
51 – 60 8 4 
61 – 70 10 7 
>70 4 1 
 
TABLE 6 
CORRELATION BETWEEN MICROALBUMINURIA AND 
HEMOGLOBIN 
HEMOGLOBIN 
IN GM% 
MICROALBUMINURIA 
PRESENT                             ABSENT 
<11 1 2 
11 – 13 8 6 
>13 16 17 
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TABLE 7 
CORRELATION BETWEEN MICROALBUMINURIA AND 
FASTING BLOOD SUGAR 
FASTING BLOOD 
SUGAR IN GM % 
MICROALBUMINURIA 
PRESENT              ABSENT 
<=126 3 4 
>126 22 21 
 
TABLE 8 
CORRELATION BETWEEN MICROALBUMINURIA AND LEFT 
VENTRICULAR HYPERTROPHY 
ECG                MICROALBUMINURIA 
PRESENT                  ABSENT 
NORMAL 18 23 
LEFT 
VENTRICULAR 
HYPERTROPHY 
7 2 
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TABLE 9 
CORRELATION BETWEEN MICROALBUMINURIA AND 
TREATMENT COMPLIANCE 
TREATMENT MICROALBUMINURIA 
PRESENT                    ABSENT 
REGULAR 8 20 
IRREGULAR 17 5 
 
TABLE 10 
CORRELATION BETWEEN MICROALBUMINURIA AND 
DURATION OF HYPERTENSION IN YEARS 
DURATION IN 
YEARS 
MICROALBUMINURIA 
 
PRESENT                                     
ABSENT 
<10 15 21 
>10 10 4 
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TABLE 11 
 
CORRELATION BETWEEN MICROALBUMINURIA AND 
CREATININE 
 
CREATININE IN MG% MICROALBUMINURIA 
 
PRESENT                ABSENT 
<=1 19 21 
>1 6 4 
 
 
 
TABLE 12 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION WIDTH  
AND DIASTOLIC BLOOD PRESSURE IN MM HG 
 
DIASTOLIC BLOOD 
PRESSURE IN MM 
HG 
RED CELL DISTRIBUTION 
WIDTH 
 
11 – 12.99                          13 – 15 
<=80 11 8 
>80 8 23 
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TABLE 13 
CORRELATION BETWEEN RED CELL DISTRIBUTION WIDTH 
AND SYSTOLIC BLOOD PRESSURE IN MMHG 
 
SYSTOLIC 
BLOOD 
PRESSURE IN 
MMHG 
RED CELL DISTRIBUTION WIDTH 
 
11 – 12.99                        13 – 15 
<120 8 3 
121 – 140 5 5 
141 – 160 4 13 
>160 2 10 
 
 
TABLE 14 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND AGE 
 
AGE IN YRS RED CELL DISTRIBUTION WIDTH 
 
11 - 12.99                                      13 – 15 
<=50 12 4 
51 – 60 3 9 
61 – 70 4 13 
>70 0 5 
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TABLE 15 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND GENDER 
 
 
SEX 
 
RED CELL DISTRIBUTION WIDTH 
 
 11 – 12.99                13 – 15 
MALE 15 21 
FEMALE 4 10 
 
 
TABLE 16 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND HEMOGLOBIN 
 
HEMOGLOBIN 
IN GM% 
 
RED CELL DISTRIBUTION WIDTH 
 
11 – 12.99                        13 - 15 
<11 1 2 
11 -13 5 9 
>13 13 20 
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TABLE 17 
 
CORRELATION BETWEEN RED CELL DISTRIBUTIONS  
WIDTH AND FASTING BLOOD SUGAR 
 
 
FASTING BLOOD   
SUGAR IN MG% 
 
RED CELL DISTRIBUTION WIDTH 
 
 
11 – 12.99                     13 - 15 
 
< =126 
 
3 
 
4 
 
>126 
 
16 
 
27 
 
 
 
TABLE 18 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION WIDTH  
AND  LEFT VENTRICULAR HYPERTROPHY 
 
 
ECG 
RED CELL DISTRIBUTION 
WIDTH 
 
11 – 12.99                      13 - 15 
 
NORMAL 
 
18 
 
23 
 
LEFT VENTRICULAR 
HYPERTROPHY 
 
1 
 
8 
 
 
 
 
 73 
 
TABLE 19 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND TREATMENT COMPLIANCE 
 
 
TREATMENT RED CELL DISTRIBUTION WIDTH 
 
11 – 12.99                                   13 - 15 
REGULAR 14 14 
IRREGULAR 5 17 
 
 
TABLE 2O 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND DURATION OF HYPERTENSION 
 
 
DURATION 
INYEARS 
RED CELL DISTRIBUTION WIDTH 
 
 
11 – 12.99                              13 - 15 
<10 17 19 
>10 2 12 
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TABLE 21 
 
CORRELATION BETWEEN RED CELL DISTRIBUTION  
WIDTH  AND SERUM CREATININE 
 
 
SERUM  
CREATININE IN 
MG% 
RED CELL DISTRIBUTION 
WIDTH 
11 – 12.99     13 - 15 
 
<=1 
 
16 
 
24 
 
>1 
 
3 
 
7 
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STATISTICAL ANALYSIS 
TABLE 22 
    Microalbuminuria Total 
  
P value 
    Present Absent 
RCDW 11-13 Count 1 18 19  
 
 
 
 
 
<0.001** 
    % within 
RCDW 
5.3% 94.7% 100.0% 
    % within 
Microalbumi
nuria 
4.0% 72.0% 38.0% 
  13-15 Count 24 7 31 
    % within 
RCDW 
77.4% 22.6% 100.0% 
    % within 
Microalbumi
nuria 
96.0% 28.0% 62.0% 
Total Count 25 25 50 
  % within 
RCDW 
50.0% 50.0% 100.0% 
  % within 
Microalbumi
nuria 
100.0% 100.0% 100.0% 
 
 76 
INFERENCE 
 Out of 50 patients 25 patients had microalbuminuria [50%], among 
them 24 persons had rcdw more than 13 [96%]. 
Among the 25 patients without microalbuminuria 7 persons had rcdw 
more than 13.  
 1 person with microalbuminuria had rcdw less than 13.  
 18 patients had rcdw <13 and no microalbuminuria. 
 The association between rcdw and microalbuminuria among 
hypertensive patients is found to be significant with  p   value of <0.001% 
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TABLE 23 
   
Microalbuminuria 
Total Present Absent 
SBP <= 120 Count 2 9 11 
% within SBP 18.2% 81.8% 100.0% 
% within 
Microalbuminu
ria 
8.0% 36.0% 22.0% 
121-140 Count 2 8 10 
% within SBP 20.0% 80.0% 100.0% 
% within 
Microalbuminu
ria 
8.0% 32.0% 20.0% 
141-160 Count 12 5 17 
% within SBP 70.6% 29.4% 100.0% 
% within 
Microalbuminu
ria 
48.0% 20.0% 34.0% 
> 160 Count 9 3 12 
% within SBP 75.0% 25.0% 100.0% 
% within 
Microalbuminu
ria 
36.0% 12.0% 24.0% 
Total Count 25 25 50 
% within SBP 50.0% 50.0% 100.0% 
% within 
Microalbuminu
ria 
100.0% 100.0% 100.0% 
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Out of 11 patients with systolic blood pressure less than 120 mm of 
hg  2 persons had microalbuminaria 
Among the 10 patiens with systolic blood pressure between 121 
and 140 mm of hg 2 persons had microalbuminuria 17  patients had 
systolic blood pressure between 141 and 160 mm 0f hg among them 12 
patients had microalbuminuria  
9 patients among the 12 showing systolic blood pressure above 160 
mm of hg had microalbuminuria  
The association between the level of increase in  systolic blood 
pressure and microalbuminuria was found to be  not statistically 
significant with p value >0.001. 
SBP
> 160141-160121-140<= 120
C
o
u
n
t
14
12
10
8
6
4
2
0
Microalbuminuria
Present
Absent
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TABLE 24 
   
RCDW 
Total 11-12.99 13-15 
SBP <120 Count 8 3 11 
% within SBP 72.7% 27.3% 100.0% 
% within 
RCDW 
42.1% 9.7% 22.0% 
120-139 Count 5 5 10 
% within SBP 50.0% 50.0% 100.0% 
% within 
RCDW 
26.3% 16.1% 20.0% 
140-159 Count 4 13 17 
% within SBP 23.5% 76.5% 100.0% 
% within 
RCDW 
21.1% 41.9% 34.0% 
> 160 Count 2 10 12 
% within SBP 16.7% 83.3% 100.0% 
% within 
RCDW 
10.5% 32.3% 24.0% 
Total Count 19 31 50 
% within SBP 38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
 
Out of 11 patients with systolic blood pressure less than 120 mm of hg 3 
persons  [27.3 %] had red cell distribution  width more than 13. 
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Among the 10 persons having systolic blood pressure between 120 
and 139 mm of hg 5 patients [50%]  had red cell distribution  width more 
than 13. 
Of  the 17 persons having systolic blood pressure between 140 and 
159 mm of hg , 13 persons[76.5%] had red cell distribution  width more 
than 13. 
10 persons [83.3%] among the 12 persons showing systolic blood 
pressure more than 160 mm of hg had red cell distribution  width more 
than 13. 
The association between elevation of systolic blood pressure and 
the increase in  red cell distribution  width was found to be stastically 
significant with p value of <0.001 . 
SBP
> 160141-160121-140<= 120
C
o
u
n
t
14
12
10
8
6
4
2
0
RCDW
11-13
13-15
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TABLE 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Microalbuminuria 
Total Present Absent 
DBP <= 80 Count 4 15 19 
% within 
DBP 
21.1% 78.9% 100.0% 
% within 
Microalbumi
nuria 
16.0% 60.0% 38.0% 
> 80 Count 21 10 31 
% within 
DBP 
67.7% 32.3% 100.0% 
% within 
Microalbumi
nuria 
84.0% 40.0% 62.0% 
Total Count 25 25 50 
% within 
DBP 
50.0% 50.0% 100.0% 
% within 
Microalbumi
nuria 
100.0% 100.0% 100.0% 
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DBP
> 80<= 80
C
o
u
n
t
30
20
10
0
Microalbuminuria
Present
Absent
 
 
 
 
 
 
 
  
Out of the 25 patients having microalbuminuria 21 persons [84%]  
had  diastolic blood pressure more than 80 mm of hg. 
Among the 31 persons having diastolic blood pressure more than 
80 mm of hg,  21 persons [67.7%] had microalbuminuria. 
Among the 19 patients having diastolic blood pressure less than 80 
mm of hg 4 patients [21.1%] had microalbuminuria. 
The Association Between Increase In Diastolic Blood Pressure 
And Microalbuminuria Was Found To Be Stasticaly Significant With P 
Value < 0.001. 
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TABLE 26 
 
    
RCDW 
Total 11-13 13-15 
DBP <= 80 Count 11 8 19 
% within 
DBP 
57.9% 42.1% 100.0% 
% within 
RCDW 
57.9% 25.8% 38.0% 
> 80 Count 8 23 31 
% within 
DBP 
25.8% 74.2% 100.0% 
% within 
RCDW 
42.1% 74.2% 62.0% 
Total Count 19 31 50 
% within 
DBP 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
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 Out of the 31 patients having diastolic blood pressure of more than 
80 mm of hg 23 persons [74.2%] had red cell distribution width of >13. 
 Among the 19 persons having diastolic blood pressure of less than 
80 mm of hg 8 persons [42.1%] had red cell distribution width ofmore 
than 13. 
 1 patients having red cell distribution width more than 13 , 23 
persons [74.2%] had diastolic blood pressure more than 80 mm of hg. 
 The association between increase in red cell distribution width and 
increase in diastolic blood pressure was found to be stastically significant 
with p value of <0.001 
DBP
> 80<= 80
C
o
u
n
t
30
20
10
0
RCDW
11-13
13-15
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TABLE 27 
CORRELATION BETWEEN GENDER AND 
MICROALBUMINURIA 
   Microalbuminuria Total 
    Present Absent   
Sex Male Count 16 20 36 
    % within Sex 44.4% 55.6% 100.0% 
    % within 
Microalbuminuria 
64.0% 80.0% 72.0% 
  Femal
e 
Count 
9 5 14 
    % within Sex 64.3% 35.7% 100.0% 
    % within 
Microalbuminuria 
36.0% 20.0% 28.0% 
Total Count 25 25 50 
  % within Sex 50.0% 50.0% 100.0% 
  % within 
Microalbuminuria 
100.0% 100.0% 100.0% 
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Sex
FemaleMal e
C
o
u
n
t
30
20
10
0
Microalbuminuria
Present
Absent
 
 
 Out of the 25 patients having microalbuminuria 16 persons [64%] 
were males.  And 9 patients [36%] were females. 
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TABLE 28 
    
RCDW 
Total 11-13 13-15 
Sex Male Count 15 21 36 
% within 
Sex 
41.7% 58.3% 100.0% 
% within 
RCDW 
78.9% 67.7% 72.0% 
Female Count 4 10 14 
% within 
Sex 
28.6% 71.4% 100.0% 
% within 
RCDW 
21.1% 32.3% 28.0% 
Total Count 19 31 50 
% within 
Sex 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
Sex
FemaleMal e
C
o
u
n
t
30
20
10
0
RCDW
11-13
13-15
 
 Out Of 31 Patients Having Red Cell Distribution Width  Above 13, 
21 [67.7]Were Male  And 10 [32.3]Were Female 
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TABLE 29 
    
Microalbuminuria 
Total Present Absent 
Age in years <= 50 Count 3 13 16 
% within Age 
in years 
18.8% 81.3% 100.0% 
% within 
Microalbumin
uria 
12.0% 52.0% 32.0% 
51-60 Count 8 4 12 
% within Age 
in years 
66.7% 33.3% 100.0% 
% within 
Microalbumin
uria 
32.0% 16.0% 24.0% 
61-70 Count 10 7 17 
% within Age 
in years 
58.8% 41.2% 100.0% 
% within 
Microalbumin
uria 
40.0% 28.0% 34.0% 
> 70 Count 4 1 5 
% within Age 
in years 
80.0% 20.0% 100.0% 
% within 
Microalbumin
uria 
16.0% 4.0% 10.0% 
Total Count 25 25 50 
% within Age 
in years 
50.0% 50.0% 100.0% 
% within 
Microalbumin
uria 
100.0% 100.0% 100.0% 
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Out of the 28 persons under 60 years 11 persons had 
microalbuminuria. 
Out of 22 persons above 60 years 14 had microalbuminuria. 
Age in years
> 7061-7051-60<= 50
C
o
u
n
t
14
12
10
8
6
4
2
0
Microalbuminuria
Present
Absent
 
Bar Diagram Showing Correlation Between Age And Microalbuminuria 
 
 91 
TABLE 30 
   
RCDW 
Total 11-13 13-15 
Age in years <= 50 Count 12 4 16 
% within Age 
in years 
75.0% 25.0% 100.0% 
% within 
RCDW 
63.2% 12.9% 32.0% 
51-60 Count 3 9 12 
% within Age 
in years 
25.0% 75.0% 100.0% 
% within 
RCDW 
15.8% 29.0% 24.0% 
61-70 Count 4 13 17 
% within Age 
in years 
23.5% 76.5% 100.0% 
% within 
RCDW 
21.1% 41.9% 34.0% 
> 70 Count 0 5 5 
% within Age 
in years 
.0% 100.0% 100.0% 
% within 
RCDW 
.0% 16.1% 10.0% 
Total Count 19 31 50 
% within Age 
in years 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
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 Out of the 28 persons having age less than 60 years ,13 persons had 
red cell distribution width more than 13. 
Out of the 22 persons aged more than 60 years 18 persons had red 
cell distribution width more than 13. 
 
Age in years
> 7061-7051-60<= 50
C
o
u
n
t
14
12
10
8
6
4
2
0
RCDW
11-13
13-15
 
Bar Diagram Showing Correlation Between Age And Rcdw 
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TABLE 31 
CORRELATION BETWEEN HB% AND  
MICROALBUMINURIA 
    
Microalbuminuria 
Total Present Absent 
HB% <= 11 Count 1 2 3 
% within 
HB% 
33.3% 66.7% 100.0% 
% within 
Microalbumi
nuria 
4.0% 8.0% 6.0% 
11-13 Count 8 6 14 
% within 
HB% 
57.1% 42.9% 100.0% 
% within 
Microalbumi
nuria 
32.0% 24.0% 28.0% 
> 13 Count 16 17 33 
% within 
HB% 
48.5% 51.5% 100.0% 
% within 
Microalbumi
nuria 
64.0% 68.0% 66.0% 
Total Count 25 25 50 
% within 
HB% 
50.0% 50.0% 100.0% 
% within 
Microalbumi
nuria 
100.0% 100.0% 100.0% 
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HB%
> 1311-13<= 11
C
o
u
n
t
20
10
0
Microalbuminuria
Present
Absent
 
Out of the 25 patients having microalbuminuria 1 patient had hb% 
less than 11, 8 patients had hb% between 11 and 13, 16  Patients had hb% 
more than 13. 
 
 95 
TABLE 32 
CORRELATION BETWEEN HB% AND RCDW 
   RCDW Total 
    11-13 13-15   
HB% <= 11 Count 1 2 3 
    % within 
HB% 
33.3% 66.7% 100.0% 
    % within 
RCDW 
5.3% 6.5% 6.0% 
  11-13 Count 5 9 14 
    % within 
HB% 
35.7% 64.3% 100.0% 
    % within 
RCDW 
26.3% 29.0% 28.0% 
  > 13 Count 13 20 33 
    % within 
HB% 
39.4% 60.6% 100.0% 
    % within 
RCDW 
68.4% 64.5% 66.0% 
Total Count 19 31 50 
  % within 
HB% 
38.0% 62.0% 100.0% 
  % within 
RCDW 
100.0% 100.0% 100.0% 
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HB%
> 1311-13<= 11
C
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 Out of the 31 patients having red cell distribution width more than 
13, 2 persons had hb% <11.  9 persons had hb% between 11 and 13.  20 
persons had hb% >13. 
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TABLE  33 
  
Microalbuminuria 
Total 
Present Absent 
ECG Normal Count 18 23 41 
% within ECG 43.9% 56.1% 100.0% 
% within 
Microalbumin
uria 
72.0% 92.0% 82.0% 
LVH Count 7 2 9 
% within ECG 77.8% 22.2% 100.0% 
% within 
Microalbumin
uria 
28.0% 8.0% 18.0% 
Total Count 25 25 50 
% within ECG 50.0% 50.0% 100.0% 
% within 
Microalbumin
uria 
100.0% 100.0% 100.0% 
 
 Out Of The 25 Patients Having Microalbuminuria 18 Had Normal 
Ecg And 7 Persons Had Left Ventricular Hypertrophy According To 
Sokolov Criteria 
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ECG
LVHNorm al
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 Out Of  The 25 Patients Having Microalbuminuria 18 Had Normal 
Ecg And 7 Persons Had Left Ventricular Hypertrophy According To 
Sokolov Criteria 
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TABLE 34 
   
RCDW 
Total 11-13 13-15 
ECG Normal Count 18 23 41 
% within 
ECG 
43.9% 56.1% 100.0% 
% within 
RCDW 
94.7% 74.2% 82.0% 
LVH Count 1 8 9 
% within 
ECG 
11.1% 88.9% 100.0% 
% within 
RCDW 
5.3% 25.8% 18.0% 
Total Count 19 31 50 
% within 
ECG 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
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 Out of the 31 persons with red cell distribution width >13 , 23 had 
normal ecg, 8 persons had left ventricular hypertrophy.; out of 9 persons 
with left ventricular hypertrophy 8 had red cell distribution width >13. 
TABLE 35 
   
Microalbuminuria 
Total Present Absent 
Treatment Regular Count 8 20 28 
% within 
Treatment 
28.6% 71.4% 100.0% 
% within 
Microalbumin
uria 
32.0% 80.0% 56.0% 
Irregular Count 17 5 22 
% within 
Treatment 
77.3% 22.7% 100.0% 
% within 
Microalbumin
uria 
68.0% 20.0% 44.0% 
Total Count 25 25 50 
% within 
Treatment 
50.0% 50.0% 100.0% 
% within 
Microalbumin
uria 
100.0% 100.0% 100.0% 
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Treatment
IrregularRegular
C
o
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Microalbuminuria
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 Out of the 25 persons with microalbuminuria 8 were in regular 
treatment and 17 were in irregular treatment. 
 Among 22 on irregular treatment 17 had microalbuminuria 
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TABLE 36 
   
RCDW 
Total 11-13 13-15 
Treatment Regular  Count 14 14 28 
% within 
Treatment 
50.0% 50.0% 100.0% 
% within 
RCDW 
73.7% 45.2% 56.0% 
Irregular Count 5 17 22 
% within 
Treatment 
22.7% 77.3% 100.0% 
% within 
RCDW 
26.3% 54.8% 44.0% 
Total Count 19 31 50 
% within 
Treatment 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
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 Out of the 31 patients with rcdw >13 , 14 were in regular treatment 
and 17 were in irregular treatment Among the 22 with irregular treatment 
, 17 had rcdw >13. 
TABLE 37 
   
Microalbuminuria 
Total Present Absent 
Duration of 
HTN in years 
<= 10 Count 15 21 36 
% within 
Duration of 
HTN in years 
41.7% 58.3% 100.0% 
% within 
Microalbuminur
ia 
60.0% 84.0% 72.0% 
> 10 Count 10 4 14 
% within 
Duration of 
HTN in years 
71.4% 28.6% 100.0% 
% within 
Microalbuminur
ia 
40.0% 16.0% 28.0% 
Total Count 25 25 50 
% within 
Duration of 
HTN in years 
50.0% 50.0% 100.0% 
% within 
Microalbuminur
ia 
100.0% 100.0% 100.0% 
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 Out of the 25 persons with microalbuminuria, 15 persons had 
duration of hypertension <10 years, 10 had duration >10 years. 
Out of the 14 patients with duration >10 years, 10 had 
microalbuminuria. 
Duration of HTN in years
> 10<= 10
C
o
u
n
t
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20
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Microalbuminuria
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 Out of the 25 persons with microalbuminuria, 15 persons had 
duration of hypertension <10 years, 10 had duration >10 years. 
 Out of the 14 patients with duration >10 years, 10 had 
microalbuminuria. 
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TABLE 38 
    
RCDW 
Total 11-13 13-15 
Duration of 
HTN in years 
<= 10 Count 17 19 36 
% within 
Duration of 
HTN in years 
47.2% 52.8% 100.0% 
% within 
RCDW 
89.5% 61.3% 72.0% 
> 10 Count 2 12 14 
% within 
Duration of 
HTN in years 
14.3% 85.7% 100.0% 
% within 
RCDW 
10.5% 38.7% 28.0% 
Total Count 19 31 50 
% within 
Duration of 
HTN in years 
38.0% 62.0% 100.0% 
% within 
RCDW 
100.0% 100.0% 100.0% 
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Out Of  The 31 Patients With Rcdw >13, 19 Persons Had Duration 
Of Hypertension< 10 Years, And 12 Had Duration Of Hypertension >10 
Years.Among The 12persons With Duratioan >1o Years,10 Had Rcdw 
>13 
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DISCUSSION 
 Hypertension one of the major non communicable disease affecting 
a large population worldwide has been the subject of various studies 
conducted over the past several years. Renal involvement and cardio 
vascular involvement in hypertension are  the  important causes of greater 
morbidity and mortality .hypertension can cause damage to the blood 
vessels  leading to endothelial dydfunction . Vascular and endothelial 
damage in the kidneys causes derangement of glomerular filtration 
resulting in renal injury at a early stage in the course of the disease. 
Dysfunction of the blood vessels in kidneys leads to disruption of normal 
renal filtration leading to microalbuminuria which progresses to chronic 
kidney disease. 
A large number of studies have been conducted throughout the 
world to find a better marker for the early detection of renal involvement, 
which is also cost effective and reliable. 
Red cell distribution width is a hemotological index that is 
routinely reported in automatic hematological analysers. a study by lippi 
et al reported an inverse association between rcdw and kidney function 
test. Previous studies  have shown a strong association between red cell 
distribution width and  mortality risk  in patients having critical illness. 
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 In the present study attempt was made to correlate between red 
cell distribution width and microalbuminuria as markers of renal 
involvement in hypertension. 
Screening for microalbuminuria is both easy and also not 
expensive test for renal damage in hypertension. Urinary excretion of 
albumin had to be measured as a screening test in all hypertensive 
patients and if microalbuminuria is detected then intensive treatment is 
necessary for obtaining the necessary blood pressure control. Controlling 
of blood pressure reduces microalbuminuria and prevents the progression 
of renal involvement in hypertension. 
A study by alphonso et al shows a correlation between red cell 
distribution width and renal involvement in cardiovascular disease. 
In this study it was found that there was a statistically significant 
correlation between red cell distribution width and microalbuminuria in 
hypertensive patients [ p value<0.001].in other words there was a higher 
likelihood of a hypertensive patients with microalbuminuria to have an 
elevated red cell distribution width.  
The co relation between microalbuminuria and blood pressure was 
significant with increase in both systolic blood pressure [p =0.003]  and 
increase in diastolic blood pressure[p=0.001]. 
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The co relation between red cell distribution width and blood 
pressure was significant with increase in systolic blood pressure 
[p=0.002]. but not with diastolic blood pressure[p>0.01]. 
There is also a positive co relation between microalbuminuria and 
duration of hypertension [p=0.003].but there was no statistically 
significant correlation  between red cell distribution width  and duration 
of hypertension [p>0.01]. 
There is also a statistically significant correlation between 
compliance with anti hypertensive treatment and red cell distribution 
width ,with red cell distribution width being higher in patients on 
irregular treatment[p=0.003]. 
Attempt to co relate red cell distribution width raise and 
microalbuminuria with other parameters like left ventricular hypertrophy, 
gender variation, hemoglobin concentration and age was done but showed 
no statistically significant correlation. 
In this study a definite correlation between increase in red cell 
distribution width and microalbuminuria in hypertensive patients was 
observed. Hence red cell distribution width  level may serve as a potential 
marker of renal involvement and endothelial dysfunction in hypertensive 
patients. But considering the smaller size of the study further studies on 
larger population is necessary to make conclusive statements.   
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LIMITATIONS OF THE STUDY 
 
               A larger study population will be required before making any 
conclusive statements. 
 Healthy controls were not used in this particular study 
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CONCLUSION 
 The increase in red cell distribution width with increase in blood 
pressure correlated with microalbuminuria in hypertensive patients. 
 The correlation between increase in red cell distribution width and 
increase in blood pressure was more significant with systolic blood 
pressure elevation. 
 Age, gender, hemoglobin concentration, duration of hypertension 
did not show correlation between red cell distribution width and 
microalbuminuria in these hypertensive patients. 
 Microalbuminuria is more common in patients with long standing 
disease. 
 Red cell distribution width is higher in patients with poor treatment 
compliance. LIST OF ABBREVIATIONS USED 
 
 
ACE Angiotensine converting enzyme 
 
Bp Blood pressure 
 
CNS Central nervous system 
 
CT Computer tomography 
 
DBP Diastolic blood pressure 
 
DEH Duration of Essential hypertension 
 
ECG Electrocardiography 
 
ECHO Echocardiography 
 
FBS Fasting blood sugar 
 
H/o History of 
 
HDL High density lipoprotein  
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HTN Hypertension 
 
IHD Ischemic heart disease 
JGA Juxta glomerular apparatus 
JNC Joint National Committee 
LVH Left ventricular hypertrophy  
Nacl Sodiumchloride 
NIDDM Non insulin dependent diabetes mellitus 
NS Non significant 
O2 Oxygen 
 
SBP Systolic blood pressure  
Sr.Cr Serum creatinine 
TC Total cholesterol 
 
TIA Transient ischemic attack  
TSH Thyroid stimulating hormone  
UAE Urinary albumin excretion  
UK United kingdom 
VWL Von Willebrand factors 
WBC White Blood Cell 
RCDW                    Red Cell Distribution Width 
PROFORMA 
NAME:       
AGE:   
SEX: 
ADDRESS:       Op No: 
D.O.A   D.O.D                          DURATION OF HOSPITAL STAY 
HISTORY AND PAST HISTORY: 
PERSONAL HISTORY: 
TREATMENT HISTORY: 
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GENERAL EXAMINATION: Built:    Pallor:  
 Icterus: 
 Pedal oedema:             Temp:     Hydration: 
 Clubbing:   PR:                               BP: 
CVS: 
RS : 
PER ABDOMEN: 
CNS: 
INVESTIGATIONS 
      Complete haemogram including Red Cell Distribution Width 
Fasting blood sugar 
Serum Urea 
Serum Creatinine 
Triglyceride level 
Urine:  
   Spot PCR for Microalbuminuria 
ECG 
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